Healthcare on the Move
Contributor since: 2016
Latest Articles
Theravance Biopharma Is A Promising Buy Opportunity In 2018
Abiomed Continues To Be An Attractive Investment In 2018
Xeris Pharmaceuticals Is An Attractive Buy Opportunity In 2018
Alkermes Is Making All The Right Moves In 2018
Alexion Pharmaceuticals: An Impressive Rare Disease Player At The End Of 2018
This May Be A Good Time To Pick Up Aerie Pharmaceuticals In 2018
Rexahn Pharmaceuticals Is A Promising Buy In 2018
Tactile Systems Technology Has Emerged As A Promising Pick In 2018
VBL Therapeutics Is Trading Below Cash
United Therapeutics Is Making All The Right Moves In 2018
WellCare Health Making All The Right Moves
Anika Therapeutics Is A Solid Buy In October 2018
Amedisys Is A Solid Buy Opportunity In 2018
It May Be Better To Avoid Sanofi
Xencor Is An Exciting Buy Opportunity In 2018
Ziopharm Oncology Is An Attractive Buy For 2018
Vertex Pharmaceuticals Is A Solid Buy In 2018
UnitedHealth Group Is A Solid Buy For 2018
This May Be A Good Time To Pick Up Endo International In 2018
Seattle Genetics Is A Solid Buy In 2018
Pacira Pharmaceuticals Is A Solid Buy For 2018
Mallinckrodt Is An Attractive Buy Opportunity In 2018
Masimo Corporation Is A Solid Buy For 2018
Eli Lilly Is An Attractive Buy For 2018
You Should Not Miss Bristol-Myers Squibb In 2018
Celgene Has Emerged As An Attractive Buy Opportunity In 2018
Chemed Is An Attractive Buy For 2018
Gilead Sciences Is A Solid Buy In 2018
You Should Not Miss Epizyme In 2018
Endocyte Is A Solid Buy Opportunity For 2018
Emergent BioSolutions Is A Promising Investment Opportunity For 2018
Baxter Continues To Be A Solid Buy In 2018